Literature DB >> 2058946

Mechanism of action of progesterone as contraceptive for lactating women.

S Díaz1, P Miranda, A Brandeis, H Cárdenas, H B Croxatto.   

Abstract

Progesterone vaginal rings releasing 5-15 mg/day were tested as a contraceptive for lactating women. Progesterone plasma levels achieved ranged from 10 to 20 nmol/L. Pregnancy rates at the end of the year were less than 1% and 39% in treated (n = 210) and untreated (n = 236) nursing women, respectively. Around 70% of treated and 30% of untreated women were amenorrheic at 8 months post partum. The endocrine profile during the first 8 months post partum was assessed in 36 treated and 28 untreated nursing women. Pre- and postsuckling prolactin (PRL) levels were measured at 1600 hr at fortnightly intervals and E2 determinations and ovarian ultrasound were performed twice a week. Prolactin increases in response to suckling and postsuckling PRL levels were higher, E2 levels were lower, and follicular growth was arrested at earlier stages in progesterone-treated than in untreated women. The pattern observed in progesterone-treated women was similar to that in prolonged lactational amenorrhea. This suggests that progesterone increases the sensitivity of the breast-hypothalamic-pituitary system to suckling and reinforces the mechanism of lactational infertility.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058946     DOI: 10.1111/j.1749-6632.1991.tb37895.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India.

Authors:  Malabika Roy; Avishek Hazra; Ruth Merkatz; Marlena Plagianos; Mohcine Alami; L N Gaur; Kumudha Aruldas; Heather Sussman; Bruce Variano; Regine Sitruk-Ware
Journal:  Contraception       Date:  2020-05-01       Impact factor: 3.375

Review 2.  Contraception technology: past, present and future.

Authors:  Regine Sitruk-Ware; Anita Nath; Daniel R Mishell
Journal:  Contraception       Date:  2012-09-17       Impact factor: 3.375

3.  Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period.

Authors:  Candan İltemir Duvan; Elif Gözdemir; Ikbal Kaygusuz; Zeynep Kamalak; Nilgün Öztürk Turhan
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-09-01

4.  Contraceptive Technologies: Looking Ahead to New Approaches to Increase Options for Family Planning.

Authors:  Lisa B Haddad; John W Townsend; Regine Sitruk-Ware
Journal:  Clin Obstet Gynecol       Date:  2021-09-01       Impact factor: 1.966

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.